These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7317148)

  • 21. Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice.
    Tonomura Y; Yamamoto E; Kondo C; Itoh A; Tsuchiya N; Uehara T; Baba T
    Hum Exp Toxicol; 2009 May; 28(5):293-300. PubMed ID: 19661263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible dilated cardiomyopathy related to amphotericin B therapy.
    Danaher PJ; Cao MK; Anstead GM; Dolan MJ; DeWitt CC
    J Antimicrob Chemother; 2004 Jan; 53(1):115-7. PubMed ID: 14657095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment.
    Margassery S; Bastani B
    J Nephrol; 2001; 14(5):410-4. PubMed ID: 11730276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM; Lumbreras C; González-Vidal D;
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypouricemia, hypokalemia, proximal and distal tubular acidification defect following administration of outdated tetracycline: a case report.
    Chusil S; Tungsanga K; Wathanavaha A; Pansin P
    J Med Assoc Thai; 1994 Feb; 77(2):98-102. PubMed ID: 7798843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fusarium keratitis and endophthalmitis treated by intravenous ambisome].
    Avisar I; Weinberger D; Kremer I
    Harefuah; 2009 Jan; 148(1):28-9, 88. PubMed ID: 19320385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Classification of renal tubular acidosis. Recent data].
    Paillard M; Houillier P; Borensztein P
    Ann Pediatr (Paris); 1993 Feb; 40(2):81-9. PubMed ID: 8384429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation.
    Cesaro S; Zignol M; Burlina AB; Tridello G; Visintin G; Messina C
    Pediatr Transplant; 2006 Mar; 10(2):255-8. PubMed ID: 16573618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxicity of amphotericin B desoxycholate.
    Girmenia C; Gentile G; Micozzi A; Martino P
    Clin Infect Dis; 2001 Sep; 33(6):915-6. PubMed ID: 11512101
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic acidosis after kidney transplantation].
    Wołyniec W; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2005; 62(1):68-71. PubMed ID: 16053226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible nephrotoxicity associated with cephalothin therapy.
    Pasternak DP; Stephens BG
    Arch Intern Med; 1975 Apr; 135(4):599-602. PubMed ID: 1138675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
    Ullmann AJ; Sanz MA; Tramarin A; Barnes RA; Wu W; Gerlach BA; Krobot KJ; Gerth WC;
    Clin Infect Dis; 2006 Aug; 43(4):e29-38. PubMed ID: 16838223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
    Crompton JA; Alexander D; Somerville T; Shihab FS
    Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypokalemic rhabdomyolysis in a child due to amphotericin B therapy.
    Lucas da Silva PS; Iglesias SB; Waisberg J
    Eur J Pediatr; 2007 Feb; 166(2):169-71. PubMed ID: 16906399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
    Palacio C; Acebedo G; López A; Jodar JM
    Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicity of amphotericin B administered to dogs in a fat emulsion versus five percent dextrose solution.
    Randall SR; Adams LG; White MR; DeNicola DB
    Am J Vet Res; 1996 Jul; 57(7):1054-8. PubMed ID: 8807021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G; Pietrelli L; Gurwith M; Bowden R
    Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.